XML 179 R32.htm IDEA: XBRL DOCUMENT
v3.25.1

Summary of Significant Accounting Policies (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Dec. 31, 2024
Summary of Significant Accounting Policies [Abstract] |  |
Schedule of Derivative Liability Measured at Fair Value | The table below reflects the activity of derivative liability measured at fair value for the three months ended March 31, 2025:
|  | Significant Unobservable Inputs (Level 3) |
Balance of derivative liability as of January 1, 2025 |  | $ | 127,545 |
Reclassification of additional paid-in capital upon conversion |  |  | (18,853 | )
Loss from change in the fair value of derivative liability |  |  | 114,360 |
Balance of derivative liability as of March 31, 2025 |  | $ | 223,052 |
| The table below reflects the activity of derivative liability measured at fair value for the years ended December 31, 2024 and 2023:
|  | Significant Unobservable Inputs (Level 3) |
Balance of derivative liability as of January 1, 2023 |  | $ | - |
Initial fair value of derivative liability attributable to warrants issuance with May, July, and October 2023 fund raises |  |  | 213,170 |
Gain from change in the fair value of derivative liability |  |  | (188,374 | )
Balance of derivative liability as of December 31, 2023 |  |  | 24,796 |
Initial fair value of derivative liability attributable to warrants issuance with March and June 2024 fund raises |  |  | 479,468 |
Reclassification of additional paid-in capital upon conversion |  |  | (2,354 | )
Gain from change in the fair value of derivative liability |  |  | (374,365 | )
Balance of derivative liability as of December 31, 2024 |  | $ | 127,545 |
Schedule of Cash Balances by Geographic Area | At March 31, 2025 and December 31, 2024, the Company’s cash balances by geographic area were as follows:
Country: |  | March 31, 2025 |  |  | December 31, 2024 |
United States |  | $ | 1,351,923 |  |  |  | 98.7 | % |  | $ | 2,844,522 |  |  |  | 99.6 | %
China |  |  | 17,663 |  |  |  | 1.3 | % |  |  | 11,787 |  |  |  | 0.4 | %
Total cash |  | $ | 1,369,586 |  |  |  | 100.0 | % |  | $ | 2,856,309 |  |  |  | 100.0 | %
| At December 31, 2024 and 2023, the Company’s cash balances by geographic area were as follows:
Country: |  | December 31, 2024 |  |  | December 31, 2023 |
United States |  | $ | 2,844,522 |  |  |  | 99.6 | % |  | $ | 280,197 |  |  |  | 98.2 | %
China |  |  | 11,787 |  |  |  | 0.4 | % |  |  | 5,203 |  |  |  | 1.8 | %
Total cash |  | $ | 2,856,309 |  |  |  | 100.0 | % |  | $ | 285,400 |  |  |  | 100.0 | %
Schedule of Securities that were Excluded from the Diluted Per Share | The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive:
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
Options to purchase common stock |  |  | 1,451,425 |  |  |  | 47,287 |
Warrants to purchase common stock |  |  | 171,163 |  |  |  | 60,562 |
Series A convertible preferred stock (*) |  |  | - |  |  |  | 60,000 |
Series B convertible preferred stock (**) |  |  | - |  |  |  | 194,004 |
Series C convertible preferred stock (***) |  |  | 1,452,282 |  |  |  | - |
Series D convertible preferred stock (****) |  |  | 2,074,689 |  |  |  | - |
Convertible notes and related accrued interest (*****) |  |  | 234,554 |  |  |  | 90,133 |
Potentially dilutive securities |  |  | 5,384,113 |  |  |  | 451,986 |
(*) | Assumed the Series A convertible preferred stock (“Series A Preferred Stock”) was converted into shares of common stock of the Company at a conversion price of $150.00 per share.
(**) | Assumed the Series B convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $56.70 per share.
(***) | Assumed the Series C convertible preferred stock (“Series C Preferred Stock”) was converted into shares of common stock of the Company at a conversion price of $2.41 per share.
(****) | Assumed the Series D convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.
(*****) | Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $11.25 per share for the three months ended March 31, 2025. Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $67.50 and $22.50 and $15.00 per share for the three months ended March 31, 2024.
| The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive:
|  | Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Options to purchase common stock |  |  | 52,479 |  |  |  | 56,880 |
Warrants to purchase common stock |  |  | 182,996 |  |  |  | 43,035 |
Series A convertible preferred stock (*) |  |  | 60,000 |  |  |  | 60,000 |
Series B convertible preferred stock (**) |  |  | 194,004 |  |  |  | 194,004 |
Series C convertible preferred stock (***) |  |  | 1,452,282 |  |  |  | - |
Convertible notes (****) |  |  | 227,269 |  |  |  | 60,740 |
Potentially dilutive securities |  |  | 2,169,030 |  |  |  | 414,659 |
(*) | Assumed the Series A convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $150.00 per share.
(**) | Assumed the Series B convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $56.70 per share.
(***) | Assumed the Series C convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.
(****) | Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $11.25 per share for the year ended December 31, 2024. Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $67.50 and $22.50 per share for the year ended December 31, 2023.

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration